Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage and implementation of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
H.R. 3080, Water Resources Reform and Development Act of 2013.
S. 601, Water Resources Development Act of 2013.
Monitor legislative and administrative action related to health care policy.
Monitor legislative and administrative action related to drug user fees.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal.
Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013.
H.R. 4302, Protecting Access to Medicare Act.
S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013.
Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015.
Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
Draft, House tax extender legislation.
Draft, Senate tax extender legislation.
Monitor legislative and administrative action related to miscellaneous tariff legislation.
H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes.
Monitor legislative and administrative action related to trade promotion authority negotiations.
Monitor legislative and administrative action related to Trans-Pacific Partnerships.
Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Monitor implementation of the Agricultural Act of 2014 (P.L. 113-79).
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative and administrative action related to energy efficiency and energy technology.
S. 761, Energy Savings and Industrial Competitiveness Act of 2013.
Duration: February 1, 2014
to
July 11, 2014
General Issues: Chemicals/Chemical Industry , Environmental/Superfund , Health Issues , Miscellaneous Tariff Bills , Trade (Domestic & Foreign) , Agriculture , Energy/Nuclear , Clean Air & Water (Quality) , Food Industry (Safety, Labeling, etc.)
Spending: about $190,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2014: House of Representatives, U.S. Senate,
Related Foreign Entities:
Bayer AG (Leverkusen, GER); contribution to lobbying: $0; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
3rd Quarter, 2014
Dickstein & Shapiro, LLP terminated an engagement in which they represented Bayer Corporation on Oct. 20, 2014.
Original Filing: 300683200.xml
Lobbying Issues
Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Chemicals/Chemical Industry
Lobbying Issues
Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage and implementation of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
H.R. 3080, Water Resources Reform and Development Act of 2013.
S. 601, Water Resources Development Act of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to health care policy.
Monitor legislative and administrative action related to drug user fees.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal.
Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013.
H.R. 4302, Protecting Access to Medicare Act.
S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013.
Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015.
Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
Draft, House tax extender legislation.
Draft, Senate tax extender legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to miscellaneous tariff legislation.
H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Miscellaneous Tariff Bills
Lobbying Issues
Monitor legislative and administrative action related to trade promotion authority negotiations.
Monitor legislative and administrative action related to Trans-Pacific Partnerships.
Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitor implementation of the Agricultural Act of 2014 (P.L. 113-79).
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to energy efficiency and energy technology.
S. 761, Energy Savings and Industrial Competitiveness Act of 2013.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
Dickstein & Shapiro, LLP terminated an engagement in which they represented Bayer Corporation on July 11, 2014.
Original Filing: 300655666.xml
Lobbying Issues
Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Chemicals/Chemical Industry
Lobbying Issues
Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage and implementation of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
H.R. 3080, Water Resources Reform and Development Act of 2013.
S. 601, Water Resources Development Act of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to health care policy.
Monitor legislative and administrative action related to drug user fees.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal.
Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013.
H.R. 4302, Protecting Access to Medicare Act.
S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013.
Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015.
Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
Draft, House tax extender legislation.
Draft, Senate tax extender legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to miscellaneous tariff legislation.
H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Miscellaneous Tariff Bills
Lobbying Issues
Monitor legislative and administrative action related to trade promotion authority negotiations.
Monitor legislative and administrative action related to Trans-Pacific Partnerships.
Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitor implementation of the Agricultural Act of 2014 (P.L. 113-79).
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to energy efficiency and energy technology.
S. 761, Energy Savings and Industrial Competitiveness Act of 2013.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, Dickstein & Shapiro, LLP lobbied for Bayer Corporation , earning $90,000. The report was filed on July 11, 2014.
Original Filing: 300655656.xml
Lobbying Issues
Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Chemicals/Chemical Industry
Lobbying Issues
Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage and implementation of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
H.R. 3080, Water Resources Reform and Development Act of 2013.
S. 601, Water Resources Development Act of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to health care policy.
Monitor legislative and administrative action related to drug user fees.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal.
Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013.
H.R. 4302, Protecting Access to Medicare Act.
S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013.
Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015.
Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
Draft, House tax extender legislation.
Draft, Senate tax extender legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to miscellaneous tariff legislation.
H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Miscellaneous Tariff Bills
Lobbying Issues
Monitor legislative and administrative action related to trade promotion authority negotiations.
Monitor legislative and administrative action related to Trans-Pacific Partnerships.
Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitor implementation of the Agricultural Act of 2014 (P.L. 113-79).
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to energy efficiency and energy technology.
S. 761, Energy Savings and Industrial Competitiveness Act of 2013.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, Dickstein & Shapiro, LLP lobbied for Bayer Corporation , earning $90,000. The report was filed on April 21, 2014.
Original Filing: 300649092.xml
Lobbying Issues
Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Chemicals/Chemical Industry
Lobbying Issues
Monitor federal issues and legislation associated with chemical facilities regulation.
Monitor passage and implementation of FY 2014 omnibus appropriations bill (P.L. 113-76).
Monitor legislative action related to the Toxic Substances Control Act.
H.R. 3080, Water Resources Reform and Development Act of 2013.
S. 601, Water Resources Development Act of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to health care policy.
Monitor legislative and administrative action related to drug user fees.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal.
Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013.
H.R. 4302, Protecting Access to Medicare Act.
S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013.
Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015.
Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
Draft, House tax extender legislation.
Draft, Senate tax extender legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to miscellaneous tariff legislation.
H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Miscellaneous Tariff Bills
Lobbying Issues
Monitor legislative and administrative action related to trade promotion authority negotiations.
Monitor legislative and administrative action related to Trans-Pacific Partnerships.
Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitor implementation of the Agricultural Act of 2014 (P.L. 113-79).
Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislative and administrative action related to energy efficiency and energy technology.
S. 761, Energy Savings and Industrial Competitiveness Act of 2013.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
Dickstein & Shapiro, LLP filed a lobbying registration on March 30, 2014 to represent Bayer Corporation, effective Feb. 1, 2014.
Original Filing: 300632142.xml
Issue(s) they said they’d lobby about: Monitor federal issues and legislation associated with health care policy, appropriations, drug user fees, sustainable growth rate, trade promotion authority, chemical facilities regulation, as well as monitoring the implementation of the Patient Protection and Affordable Care Act. (P.L. 111-148) and others. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...